Truist lowered the firm’s price target on Viking Therapeutics (VKTX) to $95 from $120 and keeps a Buy rating on the shares. The company’s Q4 ...

A bill in the Iowa Senate would criminalize exposing minors to “obscene performances,” which LGBTQ+ advocates argue would be used to target drag events and venues that host them. Senate File 116 would ...

Economists had been expecting an overall healthy reading, with 169,000 net new jobs created in the month and the unemployment ...

The Trump administration's list of tax priorities includes eliminating a loophole that benefits private equity firms, hedge ...

Major U.S. stock indexes slid on Friday as investors digested closely watched monthly employment numbers and a sharp drop in consumer sentiment.

We think chair and CEO Marc Puig has done a commendable job sharpening Puig’s premium focus and expanding its brand collection through acquisitions, thus positioning the small beauty product maker ...

Neurocrine Biosciences Q4 earnings topped forecasts, but revenue slightly missed. Analysts see Ingrezza's long-term growth ...

U.S. President Donald Trump’s executive order imposing sanctions on the International Criminal Court could jeopardize trials ...

As the NFL wraps up the 2024 season this weekend, most of the league, including the Bills, is already on to 2025. Plans are ...

SportsLine's model locked in its NFL anytime TD props and first touchdown scorer predictions for Super Bowl 59 between the ...

Keefe Bruyette raised the firm’s price target on IntercontinentalExchange (ICE) to $186 from $178 and keeps an Outperform rating on the shares.

AT&T's strong financial performance and growth prospects make it a compelling buy with potential for significant upside ...